跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOXORUBICINA LIPOSOMAL PEGILADO DR. REDDYS 2 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DOXORUBICINA LIPOSOMAL PEGILADO DR. REDDYS 2 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION
Approved
STANDARD
DOXORUBICINA LIPOSOMAL PEGILADO DR. REDDYS 2 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION
Reddy Pharma Iberia S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 26, 2024
Approval ID
345da303506898cb
Company
Reddy Pharma Iberia S.A.
Type
Standard
Approval Details
Approval Id
345da303506898cb
Drug Cima Aemps Name
DOXORUBICINA LIPOSOMAL PEGILADO DR. REDDYS 2 MG/ML CONCENTRADO PARA DISPERSION PARA PERFUSION
Register Number
90025
Holder Company Name
Reddy Pharma Iberia S.A.
Marketing Company Name
Reddy Pharma Iberia S.A.
Authorization Date
2024-12-26
Dosage Form
CONCENTRADO PARA DISPERSIÓN PARA PERFUSIÓN
Dose
2 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Reddy Pharma Iberia S.A.
Active Ingredients
DOXORUBICINA HIDROCLORURO
2 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 26, 2024
Approval ID
345da303506898cb
Type
Standard
Back to CIMA-AEMPS Approvals